OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 14
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 14
Showing 14 citing articles:
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 5
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 5
METTL14-mediated m 6 A modification of DDIT4 promotes its mRNA stability in aging-related idiopathic pulmonary fibrosis
Dan Li, Qian Li, Yufeng Du, et al.
Epigenetics (2025) Vol. 20, Iss. 1
Open Access
Dan Li, Qian Li, Yufeng Du, et al.
Epigenetics (2025) Vol. 20, Iss. 1
Open Access
Structural optimization and biological evaluation of indolin-2-one derivatives as novel CDK8 inhibitors for idiopathic pulmonary fibrosis
Jui‐Yi Hsu, Kai‐Cheng Hsu, Ching-Hsuan Chou, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117891-117891
Closed Access
Jui‐Yi Hsu, Kai‐Cheng Hsu, Ching-Hsuan Chou, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117891-117891
Closed Access
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access
Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis
Xuanyu Wu, Xiang Xiao, Yuchen Su, et al.
Inflammopharmacology (2025)
Closed Access
Xuanyu Wu, Xiang Xiao, Yuchen Su, et al.
Inflammopharmacology (2025)
Closed Access
Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines
Shuyun Wu, Jiazhi Yi, Bin Wu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Shuyun Wu, Jiazhi Yi, Bin Wu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting mast cell activation alleviates anti-MHC I antibody and LPS-induced TRALI in mice by pharmacologically blocking the TLR3 and MAPK pathway
Xiaobin Fang, Tianjiao Song, Ling Zheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117456-117456
Open Access | Times Cited: 3
Xiaobin Fang, Tianjiao Song, Ling Zheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117456-117456
Open Access | Times Cited: 3
Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity
Margot De Marco, Anna Basile, Anna Lisa Cammarota, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116578-116578
Open Access | Times Cited: 1
Margot De Marco, Anna Basile, Anna Lisa Cammarota, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116578-116578
Open Access | Times Cited: 1
Mitophagy-Enhanced Nanoparticle-Engineered Mitochondria Restore Homeostasis of Mitochondrial Pool for Alleviating Pulmonary Fibrosis
Yi Wang, Li‐Fan Hu, Na-Hui Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32705-32722
Closed Access | Times Cited: 1
Yi Wang, Li‐Fan Hu, Na-Hui Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32705-32722
Closed Access | Times Cited: 1
Patient-centered care in pulmonary fibrosis: access, anticipate, and act
D. Hofman, Tonia Magrì, Catharina C. Moor, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
D. Hofman, Tonia Magrì, Catharina C. Moor, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 2, pp. 380-393
Open Access
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 2, pp. 380-393
Open Access
Targeting angiogenic and proliferative mediators by montelukast & trimetazidine Ameliorates thioacetamide-induced liver fibrosis in rats
Rehab S. Abdelrahman, Ahmed A Elnfarawy, Asmaa E Nashy, et al.
Toxicology and Applied Pharmacology (2024), pp. 117208-117208
Closed Access
Rehab S. Abdelrahman, Ahmed A Elnfarawy, Asmaa E Nashy, et al.
Toxicology and Applied Pharmacology (2024), pp. 117208-117208
Closed Access
SQSTM1 upregulation-induced iron overload triggers endothelial ferroptosis in nicotine-exacerbated atherosclerosis
Xiaobin Fang, X.A. Zhuang, Ling Zheng, et al.
Life Sciences (2024) Vol. 361, pp. 123330-123330
Open Access
Xiaobin Fang, X.A. Zhuang, Ling Zheng, et al.
Life Sciences (2024) Vol. 361, pp. 123330-123330
Open Access
Inhalable Carbonyl Sulfide Donor-Hybridized Selective Phosphodiesterase 10A Inhibitor for Treating Idiopathic Pulmonary Fibrosis by Inhibiting Tumor Growth Factor-β Signaling and Activating the cAMP/Protein Kinase A/cAMP Response Element-Binding Protein (CREB)/p53 Axis
Quan Wang, Xinyue Liu, Yuan Han, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 256-269
Closed Access
Quan Wang, Xinyue Liu, Yuan Han, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 256-269
Closed Access
